August 5, 2026 - Constancy Researchers

Cardiovascular Devices in 2026: July Was the Biggest FDA Approval Month in Years. Abbott Got CardioMEMS Hero Cleared. And the SYMPHONY-PE Trial Just Changed PE Treatment Forever.

The February Approval That Matters More Than Its Size Suggests On February 27, 2026, the

Diagnostic Imaging in 2026: The FDA Cleared 92 AI Devices in Q1 Alone. GE HealthCare Now Has 130 AI Authorizations. And Radiology Is Running the Fastest Regulatory Machine in All of Medicine.

92 AI Devices in One Quarter. 75% of Them for Radiology. The pace of AI-enabled

Orthopedic Devices in 2026: Stryker Has 3,000 MAKO Systems Installed. Over 50% of Global Knee Procedures Are Now Robot-Assisted. And the Ambulatory Surgery Centre Is the Market’s New Battlefield.

3,000 Systems. 50% of Global Knee Procedures. Robotic Surgery Is No Longer Optional. The single

Diabetes Care Devices in 2026: Dexcom Stelo Is OTC. Abbott Has the First Dual Glucose-Ketone Sensor. And the Omnipod 5 Is About to Pair with Libre 3 Plus.

ADA 2026: The Research Moments That Will Reshape Clinical Practice The American Diabetes Association’s 2026

In Vitro Diagnostics in 2026: Abbott Acquired Exact Sciences. The FDA Approved the Largest Liquid Biopsy Panel in History. UnitedHealth Now Covers Shield for 40 Million Americans.

Abbott Acquires Exact Sciences: The IVD Market’s Most Strategic Deal of the Year The in